Medicare Enrolled
Dr. Dianne Petrone, M.D.
Rheumatology · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Petrone from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Petrone?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Petrone
Dr. Dianne Petrone is a rheumatology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Petrone performed 4,888 Medicare services across 1,466 unique beneficiaries.
Between the years covered by Open Payments, Dr. Petrone received a total of $507,934 from 53 pharmaceutical and/or device companies across 2151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Petrone is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 43% volume in TX
$507,934 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,888
Medicare services
Top 43% in TX for rheumatology
1,466
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~257 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,860 | $18 | $23 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
568 | $85 | $131 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
430 | $10 | $14 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
419 | $4 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
386 | $7 | $10 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
334 | $5 | $7 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
192 | $3 | $4 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
75 | $23 | $29 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
73 | $29 | $30 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
61 | $105 | $136 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
44 | $6 | $6 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
41 | $16 | $17 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
39 | $2 | $2 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
33 | $58 | $79 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
31 | $15 | $16 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
30 | $14 | $16 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
28 | $38 | $52 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
25 | $13 | $14 |
| Iron level test | 23 | $6 | $6 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
23 | $7 | $7 |
| Thyroid hormone evaluation A blood test to measure the levels of thyroid hormones in the body. This evaluation helps assess how well the thyroid gland is functioning. |
23 | $6 | $6 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
22 | $9 | $9 |
| New patient office visit, complex (60-74 min) | 21 | $174 | $222 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
18 | $32 | $41 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
17 | $12 | $12 |
| Complement function test A blood test that measures the activity of complement proteins, which are part of the immune system. |
17 | $12 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $59 | $92 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
14 | $3 | $3 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
13 | $6 | $7 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $15 | $19 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
40.3% medium
58.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$507,934
Total received (2018-2024)
Avg $72,562/year across 7 years
Top 2% in TX for rheumatology
53
Companies
2,151
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$440,843 (86.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$50,210 (9.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,881 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$51,035
2023
$46,644
2022
$51,011
2021
$40,974
2020
$56,402
2019
$127,589
2018
$134,279
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Scientific Affairs, LLC
$80,935
Janssen Biotech, Inc.
$66,374
Lilly USA, LLC
$64,472
AbbVie, Inc.
$60,356
Novartis Pharmaceuticals Corporation
$53,584
Amgen Inc.
$52,079
E.R. Squibb & Sons, L.L.C.
$35,342
ABBVIE INC.
$27,539
AbbVie Inc.
$20,969
GENZYME CORPORATION
$16,584
Horizon Therapeutics plc
$9,735
UCB, Inc.
$4,931
Celgene Corporation
$2,745
NOVARTIS PHARMACEUTICALS CORPORATION
$2,670
Gilead Sciences, Inc.
$1,350
PFIZER INC.
$1,261
AstraZeneca Pharmaceuticals LP
$1,120
Aurinia Pharma U.S., Inc.
$851
GlaxoSmithKline, LLC.
$686
Mallinckrodt Hospital Products Inc.
$408
SANOFI-AVENTIS U.S. LLC
$395
Alexion Pharmaceuticals, Inc.
$358
Mallinckrodt Enterprises LLC
$339
Boehringer Ingelheim Pharmaceuticals, Inc.
$331
ANI Pharmaceuticals, Inc.
$300
Regeneron Healthcare Solutions, Inc.
$300
Mallinckrodt LLC
$264
Genentech USA, Inc.
$224
Fresenius Kabi USA, LLC
$201
Radius Health, Inc.
$175
Johnson & Johnson Health Care Systems Inc.
$150
Organon LLC
$93
Janssen Research & Development, LLC
$82
Antares Pharma, Inc.
$72
Horizon Pharma plc
$53
DePuy Synthes Sales Inc.
$53
Pacira Therapeutics, Inc.
$52
MEDEXUS PHARMA, INC.
$50
Ferring Pharmaceuticals Inc.
$46
Kiniksa Pharmaceuticals International, plc
$42
Bioventus LLC
$42
Hikma Pharmaceuticals USA
$40
MEDAC PHARMA, INC.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$37
Merck Sharp & Dohme Corporation
$33
Organon Llc
$31
Celltrion USA Inc.
$28
Exeltis, USA Inc.
$28
HOSPIRA, INC.
$21
TerSera Therapeutics LLC
$19
Flexion Therapeutics, Inc.
$18
SOBI, INC
$16
Ironwood Pharmaceuticals, Inc
$13
Top 3 companies account for 41.7% of total payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · Durolane · EUFLEXXA · EVENITY · Enbrel · FORTEO · HUMIRA · HYQVIA · Humira · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Kineret · LINZESS · LUPKYNIS · LYRICA · MONOVISC · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SYNVISC-ONE · Sotyktu · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · ULTOMIRIS · Ultomiris · VPRIV · XELJANZ · YUFLYMA · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for rheumatology in TX.
Equivalent to $10,391 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
95
Per 100K population
3.6
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Petrone is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Petrone experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Petrone performed 1,860 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Petrone receive payments from pharmaceutical companies?
Yes. Dr. Petrone received a total of $507,934 from 53 companies across 2,151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Petrone's costs compare to other rheumatologists in Dallas?
Dr. Petrone's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Petrone) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Dallas
Browse rheumatologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology